Barclays Initiates Coverage On Alpha Tau Medical with Overweight Rating, Announces Price Target of $15

Barclays analyst Lukas Shumway initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Overweight rating and announces Price Target of $15.